(Q24244676)

1

0 references

Lara Maxwell

2

0 references

Maria Judd

3

0 references

Michelle Catton

4

0 references

Marc C Hochberg

Cochrane Database of Systematic Reviews

5

0 references

publication date

25 January 2006

0 references

published in

0 references

cites work

The IPSO study: ibuprofen, paracetamol study in osteoarthritis. A randomised comparative clinical study comparing the efficacy and safety of ibuprofen and paracetamol analgesic treatment of osteoarthritis of the knee or hip.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Analgesic efficacy and safety of nonprescription doses of naproxen sodium compared with acetaminophen in the treatment of osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Paracetamol in osteoarthritis of the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

The therapeutic use of acetaminophen in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Key questions concerning paracetamol and NSAIDs for osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-Inflammatory Dr

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Mechanism of action of paracetamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

The effects of specific medical conditions on the functional limitations of elders in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Pharmacological therapy of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

What a difference a year makes: reflections on the ACR recommendations for the medical management of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Analgesics and osteoarthritis: are treatment guidelines reflected in clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

The role of paracetamol in chronic pain: an evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Subverting randomization in controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Treatment of osteoarthritis with acetaminophen: efficacy, safety, and comparison with nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

The role of acetaminophen in the management of patients with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

An update on the epidemiology of knee and hip osteoarthritis with a view to prevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

The verdict favors nonsteroidal antiinflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

Costs and outcomes in rheumatoid arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

Renal Effects of Prostaglandins and Clinical Adverse Effects of Nonsteroidal Anti-Inflammatory Agents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

Paracetamol and phenacetin.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

Osteoarthritis: new insights. Part 2: treatment approaches.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004257.PUB2

7 January 2021

10.1002/14651858.CD004257.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

16437479

1 reference

Consolidated OpenCitations Corpus – April 2017